| Review Article Online Published: 02 Sep 2026 | ||||||||||||
IJMDC. 2026; 10(9): 2761-2773 Intravenous ketamine compared to intranasal esketamine for treatment resistant major depressive disorder. a meta-analysis of randomized controlled trials for efficacy and pharmacovigilance outcomes Osama Homod Aldoweesh, Reham Taresh Ghazwani, Joud Aldhahery, Anhar Mohammed, Moath Alkathiri, Fahad Almatham, Ahmed Y. Azzam.
| ||||||||||||
| How to Cite this Article |
| Pubmed Style Aldoweesh OH, Ghazwani RT, Aldhahery J, Mohammed A, Alkathiri M, Almatham F, Azzam AY. Intravenous ketamine compared to intranasal esketamine for treatment resistant major depressive disorder. a meta-analysis of randomized controlled trials for efficacy and pharmacovigilance outcomes. IJMDC. 2026; 10(9): 2761-2773. doi:10.24911/IJMDC.51-1774801754 Web Style Aldoweesh OH, Ghazwani RT, Aldhahery J, Mohammed A, Alkathiri M, Almatham F, Azzam AY. Intravenous ketamine compared to intranasal esketamine for treatment resistant major depressive disorder. a meta-analysis of randomized controlled trials for efficacy and pharmacovigilance outcomes. https://www.ijmdc.com/?mno=315612 [Access: September 19, 2026]. doi:10.24911/IJMDC.51-1774801754 AMA (American Medical Association) Style Aldoweesh OH, Ghazwani RT, Aldhahery J, Mohammed A, Alkathiri M, Almatham F, Azzam AY. Intravenous ketamine compared to intranasal esketamine for treatment resistant major depressive disorder. a meta-analysis of randomized controlled trials for efficacy and pharmacovigilance outcomes. IJMDC. 2026; 10(9): 2761-2773. doi:10.24911/IJMDC.51-1774801754 Vancouver/ICMJE Style Aldoweesh OH, Ghazwani RT, Aldhahery J, Mohammed A, Alkathiri M, Almatham F, Azzam AY. Intravenous ketamine compared to intranasal esketamine for treatment resistant major depressive disorder. a meta-analysis of randomized controlled trials for efficacy and pharmacovigilance outcomes. IJMDC. (2026), [cited September 19, 2026]; 10(9): 2761-2773. doi:10.24911/IJMDC.51-1774801754 Harvard Style Aldoweesh, O. H., Ghazwani, . R. T., Aldhahery, . J., Mohammed, . A., Alkathiri, . M., Almatham, . F. & Azzam, . A. Y. (2026) Intravenous ketamine compared to intranasal esketamine for treatment resistant major depressive disorder. a meta-analysis of randomized controlled trials for efficacy and pharmacovigilance outcomes. IJMDC, 10 (9), 2761-2773. doi:10.24911/IJMDC.51-1774801754 Turabian Style Aldoweesh, Osama Homod, Reham Taresh Ghazwani, Joud Aldhahery, Anhar Mohammed, Moath Alkathiri, Fahad Almatham, and Ahmed Y. Azzam. 2026. Intravenous ketamine compared to intranasal esketamine for treatment resistant major depressive disorder. a meta-analysis of randomized controlled trials for efficacy and pharmacovigilance outcomes. International Journal of Medicine in Developing Countries, 10 (9), 2761-2773. doi:10.24911/IJMDC.51-1774801754 Chicago Style Aldoweesh, Osama Homod, Reham Taresh Ghazwani, Joud Aldhahery, Anhar Mohammed, Moath Alkathiri, Fahad Almatham, and Ahmed Y. Azzam. "Intravenous ketamine compared to intranasal esketamine for treatment resistant major depressive disorder. a meta-analysis of randomized controlled trials for efficacy and pharmacovigilance outcomes." International Journal of Medicine in Developing Countries 10 (2026), 2761-2773. doi:10.24911/IJMDC.51-1774801754 MLA (The Modern Language Association) Style Aldoweesh, Osama Homod, Reham Taresh Ghazwani, Joud Aldhahery, Anhar Mohammed, Moath Alkathiri, Fahad Almatham, and Ahmed Y. Azzam. "Intravenous ketamine compared to intranasal esketamine for treatment resistant major depressive disorder. a meta-analysis of randomized controlled trials for efficacy and pharmacovigilance outcomes." International Journal of Medicine in Developing Countries 10.9 (2026), 2761-2773. Print. doi:10.24911/IJMDC.51-1774801754 APA (American Psychological Association) Style Aldoweesh, O. H., Ghazwani, . R. T., Aldhahery, . J., Mohammed, . A., Alkathiri, . M., Almatham, . F. & Azzam, . A. Y. (2026) Intravenous ketamine compared to intranasal esketamine for treatment resistant major depressive disorder. a meta-analysis of randomized controlled trials for efficacy and pharmacovigilance outcomes. International Journal of Medicine in Developing Countries, 10 (9), 2761-2773. doi:10.24911/IJMDC.51-1774801754 |